Opportunity Information: Apply for PA 24 179
The NIH Independent Scientist Award (K02) is a career development grant meant to help newly independent researchers strengthen and expand their research programs at a key transition point in their careers. Its central goal is to foster the growth of outstanding scientists by giving them a sustained period of support to deepen their expertise, increase productivity, and position themselves to make major contributions in their research area. Rather than functioning like a traditional project grant that primarily funds a set of experiments, the K02 is designed to invest in the investigator by creating a stable window of time and resources for intensive research focus.
A defining feature of this opportunity is the provision of three to five years of salary support tied to protected time for research. In practical terms, this mechanism is intended to reduce competing demands (often heavy teaching, administrative, or clinical loads) so the awardee can concentrate on building a stronger, more influential research trajectory. Because applicants come from different disciplines and career situations, NIH emphasizes that each K02 career award plan should be tailored to the individual candidate, reflecting their specific development needs and the steps required to advance their independence and impact.
This particular parent Funding Opportunity Announcement (PA-24-179) is specifically for applicants whose proposed research does not involve leading an independent clinical trial. It also excludes leading a clinical trial feasibility study or leading a separate ancillary clinical trial. The distinction matters: applicants can still gain experience related to clinical trials, but only in a non-leading role. For example, it is allowable to propose participating in a clinical trial that is led by another investigator as part of the applicant's research and career development experience. If the applicant intends to serve as the lead investigator of a clinical trial or an ancillary clinical trial, NIH directs them to apply under the companion FOA that permits independent clinical trials, rather than this one.
Eligibility is broad and spans many types of U.S.-based organizations, including public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and multiple levels of government entities (state, county, city/township, special districts), as well as independent school districts and public housing authorities/Indian housing authorities. The announcement also highlights categories of institutions and organizations often emphasized in federal research programs, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with eligible federal agencies and faith-based or community-based organizations. Federally recognized Native American tribal governments and other tribal organizations are included among eligible applicants as well.
The FOA includes important limits related to foreign involvement. Non-domestic (non-U.S.) entities are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as NIH defines them in the NIH Grants Policy Statement, are allowed, meaning a U.S. applicant organization may be able to incorporate certain foreign elements into the research when appropriately justified and consistent with NIH policy, even though the applicant organization itself must be domestic.
Administratively, this is an NIH discretionary grant opportunity in the education and health activity categories, listed under multiple CFDA numbers (93.121, 93.273, 93.279, 93.310, 93.313, 93.853, 93.866), reflecting that different NIH Institutes and Centers may use the parent K02 mechanism across a range of scientific areas. The opportunity number is PA-24-179, it was created on 2024-04-24, and the listed original closing date is 2027-05-07. The posted summary does not specify an award ceiling or the expected number of awards, which is common for NIH parent announcements where budgets and award counts can vary by institute, fiscal year, and program priorities.
Overall, this K02 parent announcement is best understood as a structured way for a newly independent scientist to secure multi-year salary support and protected research time, with a personalized career development strategy, while staying within a research scope that does not place the applicant in the role of leading an independent clinical trial.Apply for PA 24 179
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.273, 93.279, 93.310, 93.313, 93.853, 93.866.
- This funding opportunity was created on 2024-04-24.
- Applicants must submit their applications by 2027-05-07.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Request for Information for USAID/Namibia Key Populations - Resilience, Innovation, Sustainability, and Empowerment (KP-RISE)
Previous opportunity: Tuberculosis Elimination and Laboratory Cooperative Agreement
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 24 179
Applicants also applied for:
Applicants who have applied for this opportunity (PA 24 179) also looked into and applied for these:
| Funding Opportunity |
|---|
| Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional) Apply for RFA NR 24 006 Funding Number: RFA NR 24 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) Apply for PA 24 180 Funding Number: PA 24 180 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) Apply for PAR 24 207 Funding Number: PAR 24 207 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics (U54 Clinical Trials Not Allowed) Apply for RFA DA 25 056 Funding Number: RFA DA 25 056 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,900,000 |
| HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required) Apply for RFA DA 25 025 Funding Number: RFA DA 25 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: $5,000,000 |
| HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional) Apply for RFA DA 25 061 Funding Number: RFA DA 25 061 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional) Apply for RFA DA 25 026 Funding Number: RFA DA 25 026 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional) Apply for RFA DA 25 062 Funding Number: RFA DA 25 062 Agency: National Institutes of Health Category: Education, Health Funding Amount: $2,250,000 |
| Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional) Apply for RFA CA 24 027 Funding Number: RFA CA 24 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Translational Resource Centers to Build Bridges Between Substance Use Epidemiology/Etiology and Prevention Intervention Research (U24 Clinical Trials Not Allowed) Apply for RFA DA 25 040 Funding Number: RFA DA 25 040 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional) Apply for RFA DA 25 050 Funding Number: RFA DA 25 050 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional) Apply for RFA DA 25 049 Funding Number: RFA DA 25 049 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R01 Clinical Trial Not Allowed) Apply for RFA MH 25 180 Funding Number: RFA MH 25 180 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R21 Clinical Trial Not Allowed) Apply for RFA MH 25 181 Funding Number: RFA MH 25 181 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) Apply for PAR 24 238 Funding Number: PAR 24 238 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) Apply for PAR 24 239 Funding Number: PAR 24 239 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed) Apply for RFA DA 25 045 Funding Number: RFA DA 25 045 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 25 044 Funding Number: RFA DA 25 044 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Novel Preclinical Models of NeuroHIV in the cART Era (R61/R33 - Clinical Trial Not Allowed) Apply for RFA NS 24 035 Funding Number: RFA NS 24 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required) Apply for RFA DA 25 057 Funding Number: RFA DA 25 057 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 24 179", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
